nach oben

Neurological Sciences

Erschienen in:

13.02.2020 | Original Article

Low TSH level predicts a poor clinical outcome in patients with anterior circulation ischemic stroke after endovascular thrombectomy

verfasst von: Zhongyun Chen, Yijia Sun, Yingbo Zhang, Yanbo He, Hongbo Chen, Yingying Su

Erschienen in: Neurological Sciences | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Objective

To determine the correlation of thyroid hormone status with hemorrhagic transformation (HT) and short-term clinical outcomes in patients with acute ischemic stroke (AIS) after endovascular thrombectomy (EVT)

Methods

A retrospective analysis was conducted on AIS patients who underwent EVT at our hospital from 2016 to 2019. Thyroid-stimulating hormone (TSH), total triiodothyronine (TT3), free triiodothyronine (FT3), total thyroxine (TT4), and free thyroxine (FT4) levels were assessed, and logistic regression analyses were performed with HT incidence and functional outcome at 3 months.

Results

A total of 199 patients (148 males; mean age 62.9 ± 13.1 years) were included in the study. The number of patients with HT and unfavorable functional outcomes at 3 months were 74 (37.2%) and 129 (64.8%), respectively. Multiple logistic regression analysis showed that low TSH level (OR = 0.609; 95% CI 0.402–0.920, 푃 = 0.019) was an independent risk factor of poor functional outcome, while none of the thyroid hormones were significantly associated with HT risk. The optimal cutoff value of TSH that best distinguished both unfavorable outcome (sensitivity 31%, specificity 88.6%, area under the curve (AUC) 0.586) and mortality at 3 months (sensitivity 47.4%, specificity 78.3%, AUC 0.606) was 0.485 uIU/ml.

Conclusion

A lower TSH value upon admission may predict an unfavorable functional outcome in AIS patients after EVT, but thyroid hormone levels have no bearing on the risk of HT.

Lin Y, Schulze V, Brockmeyer M, Parco C, Karathanos A, Heinen Y, Gliem M, Hartung HP, Antoch G, Jander S, Turowski B, Perings S, Kelm M, Wolff G (2019) Endovascular thrombectomy as a means to improve survival in acute ischemic stroke: a meta-analysis. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2019.0525

Badhiwala JH, Nassiri F, Alhazzani W, Selim MH, Farrokhyar F, Spears J, Kulkarni AV, Singh S, Alqahtani A, Rochwerg B, Alshahrani M, Murty NK, Alhazzani A, Yarascavitch B, Reddy K, Zaidat OO, Almenawer SA (2015) Endovascular thrombectomy for acute ischemic stroke: a meta-analysis. Jama 314(17):1832–1843. https://doi.org/10.1001/jama.2015.13767CrossRefPubMed

Le Bouc R, Clarencon F, Meseguer E, Lapergue B, Consoli A, Turc G, Naggara O, Duong DL, Servan J, Reiner P, Labeyrie MA, Fisselier M, Blanc R, Farhat W, Pires C, Zuber M, Obadia M, Mazighi M, Pico F, Mas JL, Amarenco P, Samson Y (2018) Efficacy of endovascular therapy in acute ischemic stroke depends on age and clinical severity. Stroke 49(7):1686–1694. https://doi.org/10.1161/strokeaha.117.020511CrossRefPubMed

Tsai JP, Mlynash M, Christensen S, Kemp S, Kim S, Mishra NK, Federau C, Nogueira RG, Jovin TG, Devlin TG, Akhtar N, Yavagal DR, Bammer R, Straka M, Zaharchuk G, Marks MP, Albers GW, Lansberg MG (2018) Time from imaging to endovascular reperfusion predicts outcome in acute stroke. Stroke 49(4):952–957. https://doi.org/10.1161/strokeaha.117.018858CrossRefPubMedPubMedCentral

Zi W, Wang H, Yang D, Hao Y, Zhang M, Geng Y, Lin M, Wan Y, Shi Z, Zhou Z, Wang W, Xu H, Tian X, Lv P, Wang S, Liu W, Wang Z, Liu X, Guo F, Zheng D, Li H, Tu M, Jin P, Xiao G, Liu Y, Xu G, Xiong Y, Liu X (2017) Clinical effectiveness and safety outcomes of endovascular treatment for acute anterior circulation ischemic stroke in China. Cerebrovasc Dis (Basel, Switzerland) 44(5–6):248–258. https://doi.org/10.1159/000478667CrossRef

Wang J, Li F, Xiao L, Peng F, Sun W, Li M, Liu D, Jiang Y, Guo R, Li H, Zhu W, Xu G, Liu X (2018) Depressed TSH level as a predictor of poststroke fatigue in patients with acute ischemic stroke. Neurology 91(21):e1971–e1978. https://doi.org/10.1212/wnl.0000000000006534CrossRefPubMed

Alevizaki M, Synetou M, Xynos K, Pappa T, Vemmos KN (2007) Low triiodothyronine: a strong predictor of outcome in acute stroke patients. Eur J Clin Investig 37(8):651–657. https://doi.org/10.1111/j.1365-2362.2007.01839.xCrossRef

Delpont B, Aboa-Eboule C, Durier J, Petit JM, Daumas A, Legris N, Daubail B, Giroud M, Bejot Y (2016) Associations between thyroid stimulating hormone levels and both severity and early outcome of patients with ischemic stroke. Eur Neurol 76(3–4):125–131. https://doi.org/10.1159/000449055CrossRefPubMed

Akhoundi FH, Ghorbani A, Soltani A, Meysamie A (2011) Favorable functional outcomes in acute ischemic stroke patients with subclinical hypothyroidism. Neurology 77(4):349–354. https://doi.org/10.1212/WNL.0b013e3182267ba0CrossRefPubMed

10.

Jiang X, Xing H, Wu J, Du R, Liu H, Chen J, Wang J, Wang C, Wu Y (2017) Prognostic value of thyroid hormones in acute ischemic stroke-a meta-analysis. Sci Rep 7(1):16256. https://doi.org/10.1038/s41598-017-16564-2CrossRefPubMedPubMedCentral

11.

Lamba N, Liu C, Zaidi H, Broekman MLD, Simjian T, Shi C, Doucette J, Ren S, Smith TR, Mekary RA, Bunevicius A (2018) A prognostic role for low tri-iodothyronine syndrome in acute stroke patients: a systematic review and meta-analysis. Clin Neurol Neurosurg 169:55–63. https://doi.org/10.1016/j.clineuro.2018.03.025CrossRefPubMed

12.

Liu J, Wang D, Xiong Y, Yuan R, Tao W, Liu M (2016) Low free triiodothyronine levels are related to symptomatic intracranial hemorrhage and poor functional outcomes after intravenous thrombolysis in acute ischemic stroke patients. Neurol Res 38(5):429–433. https://doi.org/10.1080/01616412.2016.1178480CrossRefPubMed

13.

Qiu M, Fang M, Liu X (2017) Low free triiodothyronine levels predict symptomatic intracranial hemorrhage and worse short-term outcome of thrombolysis in patients with acute ischemia stroke. Medicine 96(45):e8539. https://doi.org/10.1097/md.0000000000008539CrossRefPubMedPubMedCentral

14.

Sacks D, Baxter B, Campbell BCV, Carpenter JS, Cognard C, Dippel D, Eesa M, Fischer U, Hausegger K, Hirsch JA, Hussain MS, Jansen O, Jayaraman MV, Khalessi AA, Kluck BW, Lavine S, Meyers PM, Ramee S, Rufenacht DA, Schirmer CM, Vorwerk D (2018) Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. AJNR Am J Neuroradiol 39(6):E61–e76. https://doi.org/10.3174/ajnr.A5638CrossRefPubMedPubMedCentral

15.

Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol: JASN 17(10):2937–2944. https://doi.org/10.1681/asn.2006040368CrossRefPubMed

16.

Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet (London, England) 352(9136):1245–1251. https://doi.org/10.1016/s0140-6736(98)08020-9CrossRef

17.

Wollenweber FA, Zietemann V, Gschwendtner A, Opherk C, Dichgans M (2013) Subclinical hyperthyroidism is a risk factor for poor functional outcome after ischemic stroke. Stroke 44(5):1446–1448. https://doi.org/10.1161/strokeaha.113.000833CrossRef

18.

Neidert S, Katan M, Schuetz P, Fluri F, Ernst A, Bingisser R, Kappos L, Engelter ST, Steck A, Muller B, Christ-Crain M (2011) Anterior pituitary axis hormones and outcome in acute ischaemic stroke. J Intern Med 269(4):420–432. https://doi.org/10.1111/j.1365-2796.2010.02327.xCrossRef

19.

Dhital R, Poudel DR, Tachamo N, Gyawali B, Basnet S, Shrestha P, Karmacharya P (2017) Ischemic stroke and impact of thyroid profile at presentation: a systematic review and meta-analysis of observational studies. J Stroke Cerebrovasc Dis 26(12):2926–2934. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.07.015CrossRef

20.

Lee SY, Rhee CM, Leung AM, Braverman LE, Brent GA, Pearce EN (2015) A review: radiographic iodinated contrast media-induced thyroid dysfunction. J Clin Endocrinol Metab 100(2):376–383. https://doi.org/10.1210/jc.2014-3292CrossRefPubMed

21.

Ozkan S, Oysu AS, Kayatas K, Demirtunc R, Eren M, Uslu H, Altuntas Y (2013) Thyroid functions after contrast agent administration for coronary angiography: a prospective observational study in euthyroid patients. Anatol J Cardiol 13(4):363–369. https://doi.org/10.5152/akd.2013.134CrossRef

22.

Rhee CM, Bhan I, Alexander EK, Brunelli SM (2012) Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch Intern Med 172(2):153–159. https://doi.org/10.1001/archinternmed.2011.677CrossRefPubMed

23.

Dorr M, Robinson DM, Wallaschofski H, Schwahn C, John U, Felix SB, Volzke H (2006) Low serum thyrotropin is associated with high plasma fibrinogen. J Clin Endocrinol Metab 91(2):530–534. https://doi.org/10.1210/jc.2005-1786CrossRefPubMed

24.

Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW (2006) Thyroid status, cardiovascular risk, and mortality in older adults. Jama 295(9):1033–1041. https://doi.org/10.1001/jama.295.9.1033CrossRefPubMedPubMedCentral

25.

Floriani C, Gencer B, Collet TH, Rodondi N (2018) Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update. Eur Heart J 39(7):503–507. https://doi.org/10.1093/eurheartj/ehx050CrossRefPubMed

26.

Sun J, Yao L, Fang Y, Yang R, Chen Y, Yang K, Tian L (2017) Relationship between subclinical thyroid dysfunction and the risk of cardiovascular outcomes: a systematic review and meta-analysis of prospective cohort studies. Int J Endocrinol 2017:8130796. https://doi.org/10.1155/2017/8130796CrossRefPubMedPubMedCentral

27.

Forti P, Maioli F, Coveri M, Nativio V, Arnone G, Loreti A, Zoli M, Sacquegna T, Procaccianti G (2015) Thyroid function tests and early outcomes of acute ischemic stroke in older euthyroid patients. Exp Gerontol 61:8–14. https://doi.org/10.1016/j.exger.2014.11.011CrossRefPubMed

28.

Sadana P, Coughlin L, Burke J, Woods R, Mdzinarishvili A (2015) Anti-edema action of thyroid hormone in MCAO model of ischemic brain stroke: possible association with AQP4 modulation. J Neurol Sci 354(1–2):37–45. https://doi.org/10.1016/j.jns.2015.04.042CrossRefPubMed

29.

Mokhtari T, Akbari M, Malek F, Kashani IR, Rastegar T, Noorbakhsh F, Ghazi-Khansari M, Attari F, Hassanzadeh G (2017) Improvement of memory and learning by intracerebroventricular microinjection of T3 in rat model of ischemic brain stroke mediated by upregulation of BDNF and GDNF in CA1 hippocampal region. Daru 25(1):4. https://doi.org/10.1186/s40199-017-0169-xCrossRefPubMedPubMedCentral

30.

Losi G, Garzon G, Puia G (2008) Nongenomic regulation of glutamatergic neurotransmission in hippocampus by thyroid hormones. Neuroscience 151(1):155–163. https://doi.org/10.1016/j.neuroscience.2007.09.064CrossRefPubMed

31.

Sayre NL, Sifuentes M, Holstein D, Cheng SY, Zhu X, Lechleiter JD (2017) Stimulation of astrocyte fatty acid oxidation by thyroid hormone is protective against ischemic stroke-induced damage. J Cereb Blood Flow Metab 37(2):514–527. https://doi.org/10.1177/0271678x16629153CrossRefPubMed

32.

Franchini M, Montagnana M, Manzato F, Vescovi PP (2009) Thyroid dysfunction and hemostasis: an issue still unresolved. Semin Thromb Hemost 35(3):288–294. https://doi.org/10.1055/s-0029-1222607CrossRefPubMed

33.

Elbers LPB, Squizzato A, Gerdes VEA (2018) Thyroid disorders and hemostasis. Semin Thromb Hemost 44(7):676–682. https://doi.org/10.1055/s-0038-1666825CrossRefPubMed

34.

Sara JD, Zhang M, Gharib H, Lerman LO, Lerman A (2015) Hypothyroidism is associated with coronary endothelial dysfunction in women. J Am Heart Assoc 4(8):e002225. https://doi.org/10.1161/jaha.115.002225CrossRefPubMedPubMedCentral

35.

Lu M, Yang CB, Gao L, Zhao JJ (2015) Mechanism of subclinical hypothyroidism accelerating endothelial dysfunction (review). Exp Ther Med 9(1):3–10. https://doi.org/10.3892/etm.2014.2037CrossRefPubMed

36.

Cho HJ, Kim SS, Sung SM, Jung DS (2014) Impact of thyroid autoantibodies on functional outcome in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 23(7):1915–1920. https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.02.008CrossRefPubMed

Titel: Low TSH level predicts a poor clinical outcome in patients with anterior circulation ischemic stroke after endovascular thrombectomy
verfasst von: Zhongyun Chen
Yijia Sun
Yingbo Zhang
Yanbo He
Hongbo Chen
Yingying Su
Publikationsdatum: 13.02.2020
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 7/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-020-04281-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Low TSH level predicts a poor clinical outcome in patients with anterior circulation ischemic stroke after endovascular thrombectomy

Abstract

Objective

Methods

Results

Conclusion

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2020

Selection of treatment for ictal asystole patients based on EEG and ECG with temporary cardiac pacing

Pallidal dementia with underlying sleep apnea syndrome: a case report and literature review

Autosomal dominant SPG9: intrafamilial variability and onset during pregnancy

New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases

The assessment of severe lexical disorders in Italian individuals with aphasia

Video analysis of long-term effects of levodopa-carbidopa intestinal gel on gait and posture in advanced Parkinson’s disease

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie